COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF
摘要:
Described herein are compounds of Formula I and their pharmaceutically acceptable salts, solvates, or stereoisomers thereof, as well as their uses (e.g., for degrading certain proteins such as p300/CBP proteins).
Hydroaminomethylation of Olefins with Aminomethyltrifluoroborate by Photoredox Catalysis
作者:Kazuki Miyazawa、Takashi Koike、Munetaka Akita
DOI:10.1002/adsc.201400556
日期:2014.9.15
A photocatalytic hydroaminomethylation of olefins with N‐protected aminomethyltrifluoroborates has been developed. This methodology provides a new strategy for the introduction of a primary aminomethyl group onto electron‐deficient CC bonds. This reaction constitutes a facile entry into synthetically useful γ‐aminobutyric acid (GABA) derivatives such as baclofen.
Improved Synthesis of Monoprotected 5- and 6-Amino-2-azanorbornanes
作者:Oleksandr P. Dacenko、Olga V. Manoylenko、Oleksandr O. Grygorenko、Pavel K. Mykhailiuk、Dmitriy M. Volochnyuk、Oleg V. Shishkin、Andrey A. Tolmachev
DOI:10.1080/00397911003707196
日期:2011.3.3
[image omitted] An improved synthesis of Boc-monoprotected 5- and 6-amino-2-azanorbornanes is reported. The synthetic scheme consists of five steps and allows multigram quantities of the title compounds to be obtained. The regio- and stereochemistries of the products are established by two-dimensional NMR experiments.
Wacker Oxidation of Methylenecyclobutanes: Scope and Selectivity in an Unusual Setting
作者:Jan Sietmann、Marius Tenberge、Johannes M. Wahl
DOI:10.1002/anie.202215381
日期:2023.2.6
Methylenecyclobutanes undergo Wacker oxidation towards cyclopentanones under mild reaction conditions. A semi-pinacol-type rearrangement is proposed to be responsible for the intermediary 1,2-shift, which not only explains the formation of the products, but also rationalizes the reaction outcomes in terms of site-, regio- and enantioselectivity.
COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF
申请人:[en]REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:WO2024130095A1
公开(公告)日:2024-06-20
Described herein are compounds of Formula I and their pharmaceutically acceptable salts, solvates, or stereoisomers thereof, as well as their uses (e.g., for degrading certain proteins such as p300/CBP proteins).